Furuhata S, Kameya T, Otani M, Toya S
Department of Pathology, Kitasato University School of Medicine, Kanagawa, Japan.
Hum Pathol. 1993 Jan;24(1):10-5. doi: 10.1016/0046-8177(93)90056-m.
Twenty-two consecutive cases of adenoma in acromegalic patients were studied immunohistochemically. All the tumors contained prolactin (PRL)-reactive cells (3% to 53% of the total number of tumor cells) as well as growth hormone (GH)-reactive cells (4% to 74% of the total number of tumor cells). All acromegalic cases studied were thus plurihormonal adenomas containing GH and PRL; no pure GH cell adenoma was present. Twenty cases were further examined at the ultrastructural level in conjunction with postembedding double-labeling immunoelectron microscopy; 15 of these cases were diagnosed as mixed GH cell-PRL cell adenomas. The previously diagnosed pure GH cell adenomas possibly may have contained PRL cells and thus should be considered as mixed GH cell-PRL cell adenomas. Mammosomatotroph adenomas were rare in this series. Double-labeling immunoelectron microscopy, using protein A gold particles of two different sizes, greatly facilitated the distinction among GH, PRL, and mammosomatotroph cells.
对22例肢端肥大症患者的腺瘤进行了连续病例的免疫组织化学研究。所有肿瘤均含有催乳素(PRL)反应性细胞(占肿瘤细胞总数的3%至53%)以及生长激素(GH)反应性细胞(占肿瘤细胞总数的4%至74%)。因此,所有研究的肢端肥大症病例均为含有GH和PRL的多激素腺瘤;不存在纯GH细胞腺瘤。20例病例进一步结合包埋后双标记免疫电子显微镜进行超微结构水平检查;其中15例被诊断为混合性GH细胞-PRL细胞腺瘤。先前诊断的纯GH细胞腺瘤可能含有PRL细胞,因此应被视为混合性GH细胞-PRL细胞腺瘤。本系列中乳腺生长激素细胞腺瘤罕见。使用两种不同大小的蛋白A金颗粒进行双标记免疫电子显微镜,极大地促进了GH、PRL和乳腺生长激素细胞之间的区分。